Core Insights - The "2025 International Genomics Conference on Ophthalmology (ICGEYE) and CGT Innovation and Industrial Transformation Summit" was successfully held in Shenyang, co-hosted by several organizations including Liaoning He Eye Hospital Group [2] - The conference focused on the theme "Genes, Cells, AI: Co-creating a New Landscape for Precision Treatment in Ophthalmology," gathering nearly a hundred top scientists and representatives from various sectors to discuss the integration of cell and gene therapy (CGT) with artificial intelligence in ophthalmology [2][3] - The event aims to promote the transformation of significant technological achievements and inject new momentum into the high-quality development of the ophthalmology industry [2] Industry Developments - The chairman of He Eye Hospital, Professor He Wei, highlighted that cell and gene therapy is a key development area in international medicine, with continuous technological breakthroughs and innovations emerging in recent years [3] - The conference has been held for eight consecutive years in Shenyang, facilitating cross-disciplinary integration among genomics, ophthalmology, stem cell therapy, biomedical fields, big data, and artificial intelligence [3] - The event featured four major thematic forums focusing on CGT applications and breakthroughs in ophthalmology, clinical translation advancements, anti-aging mechanisms, and capital empowerment for the ophthalmic CGT industry [3] Networking and Knowledge Sharing - The conference included deep dialogue sessions among scientists, entrepreneurs, and investors, emphasizing the connection between innovation, industry, and funding chains to explore new opportunities in the ophthalmic CGT sector [3] - Additional activities such as industry roadshows, visual health awareness events, and product exhibitions were organized to facilitate practical collaboration and public education on eye health, enhancing both academic and social value [3]
2025年国际基因组学大会眼科大会在沈阳举办